Clinical Trials Sponsored by Mindera Health

Total 50162 results

Mindera Health

Not yet recruiting

Subjects Through the Application of the Mindera Kit Part 2 (STAMP-2)

Psoriasis
Mindera Health

Not yet recruiting

A 16-week Randomized Evaluation of the Impact of Mind.Px Application on Response to Biologic Treatment in Patients Suffering From Plaque Psoriasis Through Clinical Utility and Health Outcomes. (MATCH)

Plaque Psoriasis
Montera Health Texas LLC

Not yet recruiting

Treatment Planning for ABA Employing Auxiliary Tools v2+ (TREAAT2+) (TREAAT2+)

Autism Spectrum Disorder
Minerva Neurosciences

Completed

Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Schizophrenia

Negative Symptoms of Schizophrenia

United States, Bulgaria, Poland, Ukraine
Minerva Neurosciences

Completed

A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Bulgaria, Finland, Georgia, Moldova, Republic of, Poland, Ukraine
Minerva Neurosciences

Completed

A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects

Healthy Subjects

Ireland
Minerva Neurosciences

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

Negative Symptoms in Schizophrenia

United States
Minerva Neurosciences

Completed

A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers

Healthy Subjects

Ireland
Minerva Neurosciences

Completed

Pharmacokinetic Study of MIN-101 in Healthy Subjects

Schizophrenia

United Kingdom
Minerva Surgical, Inc.

Completed

Registry Study of Genesys HTA for Treatment of Menorrhagia (Genesys HTA)

Menorrhagia

United States
Minerva Surgical, Inc.

Completed

A Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System

Menorrhagia Due to Benign Causes

Mexico
Minerva Surgical, Inc.

Completed

A Multi-Center, Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System

Menorrhagia Due to Benign Causes

Canada
Kindeva Drug Delivery

Completed

Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients

Asthma

United States
Kindeva Drug Delivery

Completed

Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate

Healthy

United Kingdom
Minerva Surgical, Inc.

Completed

Symphion® System In-Office Study

Uterine Leiomyomas | Endometrial Polyps

United States
Minerva Surgical, Inc.

Completed

Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation

Menorrhagia

United States, Canada, Mexico
Minerva Surgical, Inc.

Completed

A Two-Phase Clinical Study of the Minerva AURORA Ablation System

Menorrhagia Due to Benign Causes

Hungary
Nelson Mandela Metropolitan University

Unknown

The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis (NIA)

Multiple Sclerosis, Relapsing-Remitting

United States
Karakter Kinder- en Jeugdpsychiatrie

Not yet recruiting

Psycho-education Program BLAME-LESS and it's Effect on Traumarelated Shame and Guilt (BLAME-LESS)

Trauma

Netherlands
Idera Pharmaceuticals, Inc.

Completed

A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors (ILLUMINATE-101)

Melanoma | Refractory Solid Tumors

United States, Israel
Idera Pharmaceuticals, Inc.

Terminated

Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia (8400-401)

Waldenstrom's Macroglobulinemia

United States
Idera Pharmaceuticals, Inc.

Completed

Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma

Renal Cell Carcinoma

United States
Idera Pharmaceuticals, Inc.

Completed

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis | Actively Extending Plaque Psoriasis

United States
Karakter Kinder- en Jeugdpsychiatrie

Not yet recruiting

IBA Treatment in Adolescents With OCD

Obsessive-Compulsive Disorder in Adolescence
Hellenic Atherosclerosis Society
Minerva SA

Completed

Effect of Plant Stanol Ester-Containing Spread on Estimated Cardiovascular Risk in Comparison to Mediterranean Diet

Hypercholesterolemia

Greece
Sophies Minde Ortopedi

Completed

Antiperspirant in the Treatment of Residual Limp Hyperhidrosis for Prosthetic Users

Hyperhidrosis | Residual Limbs

Norway
Minerva A Romero Arenas

Completed

Minimizing Narcotic Analgesics After Endocrine Surgery

Parathyroid Diseases | Thyroid Diseases | Thyroid Neoplasms | Thyroid Cancer | Thyroid Nodule | Parathyroid Adenoma | Parathyroid Hyperplasia | Thyroid Goitre

United States
Indira IVF Hospital Pvt Ltd

Recruiting

Natural Cycle vs Programmed Cycle Frozen Embryo Transfer

Infertility | Frozen Embryo Transfer | Preeclampsia and Eclampsia

India
Indena S.p.A
Sintesi Research Srl

Withdrawn

Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain (IDN5243inLBP)

Low Back Pain

Italy
IRCCS San Raffaele
Indena S.p.A

Unknown

Safety of Ginkgo Biloba Leaf Extract (GiBiEx)

Healthy

Italy
Idera Pharmaceuticals, Inc.

Completed

A Phase 2 Study to Assess the Safety and Efficacy of IMO-2125 With 8 mg Ipilimumab in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
Idera Pharmaceuticals, Inc.

Completed

A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis (8400-201)

Plaque Psoriasis

Netherlands
Idera Pharmaceuticals, Inc.

Completed

Trial of IMO-8400 in Adult Patients With Dermatomyositis (8400-211)

Dermatomyositis

United States, Hungary, United Kingdom
Idera Pharmaceuticals, Inc.

Completed

Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients

Hepatitis C

United States, Puerto Rico
Idera Pharmaceuticals, Inc.

Completed

Study of Combination Treatment With IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype 1 Patients

Hepatitis C, Treatment Naïve, Genotype 1 Patients

France
Idera Pharmaceuticals, Inc.

Completed

Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401

Waldenstrom's Macroglobulinemia
Idera Pharmaceuticals, Inc.

Completed

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

Diffuse Large B Cell Lymphoma

United States
Assistance Publique - Hôpitaux de Paris
MINDRAY

Recruiting

Post Thyroidectomy Echographic Method for Study of Vocal Fold Motion (VOCALE)

Recurrent Laryngeal Nerve Palsy | Postoperative Dysphonia

France
Indira Gandhi Medical College, Shimla

Completed

Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis

Allergic Rhinitis
Klinik für Kinder- und Jugendmedizin

Completed

EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients

Epstein-Barr Virus Infections

Germany
Indira Gandhi Medical College, Shimla

Unknown

Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix

Carcinoma Cervix

India
The Hospital for Sick Children
MINDRAY

Completed

Mindray Pediatric Hematology Reference Intervals Study

Establish Hematology Reference Intervals

Canada
Indira IVF Hospital Pvt Ltd

Terminated

Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation

Infertility, Female | Frozen Embryo Transfer

India
Thorne Research Inc.
Indena S.p.A

Terminated

Effects of Quercetin on Metabolic Health

Aging | Lipid Metabolism | Quercetin

United States
Indira Gandhi Medical College, Shimla

Completed

Modafinil in Cancer Related Fatigue (ModCRF)

Quality of Life | Cancer Related Fatigue

India
AbbVie
Idera Pharmaceuticals, Inc.

Completed

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Advanced Solid Tumors Cancer

United States, France, Germany, Israel, Netherlands, Spain
M.D. Anderson Cancer Center
Indena S.p.A

Active, not recruiting

The Effects of Ginseng on Cancer-Related Fatigue

Solid Tumors | Advanced Cancers

United States
Istituto Oncologico Veneto IRCCS
Indena S.p.A

Completed

Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients (ROSAM)

Oral Mucositis | Head-and-neck Squamous Cell Carcinoma

Italy
Indira Gandhi Institute of Dental Science

Unknown

Comparison of Coronally Advanced Flap and Semilunar Incision Vestibular Technique for Multiple Gingival Recessions in Maxillary Teeth - A Randomized Controlled Trial (CAF and SVIT)

Gingival Recession, Generalized | Root Coverage

India
Indira Gandhi Institute of Dental Science

Completed

Evaluation of Remineralizing Efficacy of Combination Varnishes on White Spot Lesions in ECC Children

Child | Early Childhood Caries

3

Subscribe